Dalia A ElGamal, PhD

  • 570 Citations
  • 11 h-Index

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Dalia A ElGamal is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 570 Citations
  • 11 h-Index
  • 10 Article
  • 2 Letter

BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct bet inhibitor

Ozer, H. G., El-Gamal, D., Powell, B., Hing, Z. A., Blachly, J. S., Harrington, B., Mitchell, S., Grieselhuber, N. R., Williams, K., Lai, T. H., Alinari, L., Baiocchi, R. A., Brinton, L., Baskin, E., Cannon, M., Beaver, L., Goettl, V. M., Lucas, D. M., Woyach, J. A., Sampath, D. & 27 others, Lehman, A. M., Yu, L., Zhang, J., Ma, Y., Zhang, Y., Spevak, W., Shi, S., Severson, P., Shellooe, R., Carias, H., Tsang, G., Dong, K., Ewing, T., Marimuthu, A., Tantoy, C., Walters, J., Sanftner, L., Rezaei, H., Nespi, M., Matusow, B., Habets, G., Ibrahim, P., Zhang, C., Mathe, E. A., Bollag, G., Byrd, J. C. & Lapalombella, R., Apr 2018, In : Cancer Discovery. 8, 4, p. 458-477 20 p.

Research output: Contribution to journalArticle

  • 36 Scopus citations

    Next-generation XPO1 inhibitor shows improved efficacy and in vivo tolerability in hematological malignancies

    Hing, Z. A., Fung, H. Y. J., Ranganathan, P., Mitchell, S., El-Gamal, D., Woyach, J. A., Williams, K., Goettl, V. M., Smith, J., Yu, X., Meng, X., Sun, Q., Cagatay, T., Lehman, A. M., Lucas, D. M., Baloglu, E., Shacham, S., Kauffman, M. G., Byrd, J. C., Chook, Y. M. & 2 others, Garzon, R. & Lapalombella, R., Dec 1 2016, In : Leukemia. 30, 12, p. 2364-2372 9 p.

    Research output: Contribution to journalArticle

  • 49 Scopus citations

    Targeting BTK through microRNA in chronic lymphocytic leukemia

    Bottoni, A., Rizzotto, L., Lai, T. H., Liu, C., Smith, L. L., Mantel, R., Reiff, S., El-Gamal, D., Larkin, K., Johnson, A. J., Lapalombella, R., Lehman, A., Plunkett, W., Byrd, J. C., Blachly, J. S., Woyach, J. A. & Sampath, D., Dec 29 2016, In : Blood. 128, 26, p. 3101-3112 12 p.

    Research output: Contribution to journalArticle

  • 15 Scopus citations

    The authors reply

    El-Gamal, D., Frank, S., Hallström, S. & Marsche, G., Apr 8 2015, In : Kidney International. 87, 4, p. 861-862 2 p.

    Research output: Contribution to journalLetter

    PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL

    El-Gamal, D., Williams, K., LaFollette, T. D., Cannon, M., Blachly, J. S., Zhong, Y., Woyach, J. A., Williams, E., Awan, F. T., Jones, J., Andritsos, L., Maddocks, K., Wu, C. H., Chen, C. S., Lehman, A., Zhang, X., Lapalombella, R. & Byrd, J. C., Aug 28 2014, In : Blood. 124, 9, p. 1481-1491 11 p.

    Research output: Contribution to journalArticle

  • 30 Scopus citations